Incidence of milrinone blood levels outside the therapeutic range and their relevance in children after cardiac surgery for congenital heart disease

Intensive Care Medicine

Volumn 39, Issue 5, 2013, Pages 951-957

  Garcia Guerra, Gonzalo ^a   Joffe, Ari R ^a   Senthilselvan, Ambikaipakan ^a   Kutsogiannis, Demetrios J ^a   Parshuram, Christopher S ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Child; Congenital heart disease; Critical care; Milrinone; Pharmacology

Indexed keywords

LACTIC ACID; MILRINONE;

ARTICLE; CONGENITAL HEART DISEASE; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; FEMALE; FORWARD HEART FAILURE; HEART OUTPUT; HEART SURGERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD;

CARDIAC OUTPUT; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; LOGISTIC MODELS; MALE; MILRINONE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 84885018381     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-2858-3     Document Type: Article

References (40)

1. Bishara T, Seto WTW, Trope A, Parshuram Ch (2010) Use of milrinone in critically ill children. Can J Hosp Pharm 63(6):420-428
2. Hoffman TM, Wernovsky G, Atz AM et al (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107(7):996-1002
3. Rapundalo ST, Grupp I, Grupp G, Abdul Matlib M, Solaro RJ, Schwartz A (1986) Myocardial actions of milrinone: characterization of its mechanism of action. Circulation 73((3pt-20):III):134-144
4. Earl CQ, Linden J, Weglicki WB (1986) Inhibition of cyclic AMP-dependent protein kinase activity by the cardiotonic drugs amrinone and milrinone. Life Sci 39(20):1901-1908
5. Alousi AA, Johnson D (1986) Pharmacology of the bipyridines: amrinone and milrinone. Circulation 73((suppIII)):III10-III24
6. Sys SU, Goenen MJ, Chalant CH, Brutsaert DL (1986) Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle. Circulation 73((suppIII)):III25-III35
7. Honerjäger P (1989) Pharmacology of positive inotropic phosphodiesterase III inhibitors. Eur Heart J 10(Suppl C):25-31
8. Scholz H, Meyer W (1986) Phosphodiesterase-inhibiting properties of newer inotropic agents. Circulation 73((Supp III)):III99-III108
9. Endoh M, Yanagisawa T, Taira N, Blinks JR (1986) Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Circulation 73((3pt2)):III117-III133
10. Kauffman RF, Schenck KW, Utterback BG, Crowe VG, Cohen ML (1987) In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. J Pharmacol Exp Ther 242(3):864-872
11. Carcillo JA, Fields AI (2002) American College of Critical Care Medicine Task Force Committee M. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 30(6):1365-1378
12. Vogt W, Läer S (2011) Prevention for pediatric low cardiac output syndrome: results from the European survey EuLoCOS-Paed. Pediatric Anesthesia 21:1176-1184
13. De Luca L, Proietti P, Palombaro GL, Battagliese A, Celotto A, Bucciarelli Ducci C, Fedele F (1986) New positive inotropic agents for congestive heart failure. N Engl J Med 315(6):396-397
14. Rettig GF, Schieffer HJ (1989) Acute effects of intravenous milrinone in heart failure. Eur Heart J 10(Suppl C):39-43
15. Young RA, Ward A (1988) Milrinone. A preliminary review of its pharmacological properties and therapeutic use. Drugs 36(2):158-192
16. Bailey JM, Miller BE, Lu W, Tosone SR, Kanter KR, Tam VK (1999) The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology 90(4):1012-1018
17. Bailey JM, Levy JH, Kikura M, Szlam F, Hug CC Jr (1994) Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology 81(3):616-622
18. Prielipp RC, MacGregor DA, Butterworth JFt et al (1996) Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients. Chest 109(5):1291-1301
19. De Hert SG, Moens MM, Jorens PG, Delrue GL, DePaep RJ, Vermeyen KM (1995) Comparison of two different loading doses of milrinone for weaning from cardiopulmonary bypass. J Cardiothorac Vasc Anesth 9(3):264-271
20. Wernovsky G, Wypij D, Jonas RA (1995) Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92:2226-2235
21. Lindsay CA, Barton P, Lawless S et al (1998) Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. J Pediatr 132(2):329-334
22. Ramamoorthy C, Anderson GD, Williams GD, Lynn AM (1998) Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesth Analg 86(2):283-289
23. Bailey JM, Hoffman TM, Wessel DL et al (2004) A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodyn 31(1):43-59
24. Edelson J, Koss RF, Baker JF, Park GB (1983) High-performance liquid chromatographic analysis of milrinone in plasma and urine. Intravenous pharmacokinetics in the dog. J Chromatogr 276(2):456-462
25. Paradisis M, Jiang X, McLachlan AJ et al (2007) Population pharmacokinetics and dosing regimen design of milrinone in preterm infants. Arch Dis Child Fetal Neonatal 92(3):F204-F209
26. Cheung PY, Chui N, Joffe AR, Rebeyka IM, Robertson CM (2005) Postoperative lactate concentrations predict the outcome of infants aged 6 weeks or less after intracardiac surgery: a cohort follow-up to 18 months. J Thorac Cardiovasc Surg 130(3):837-843
27. Munoz R, Laussen PC, Palacio G, Zienko L, Piercey G, Wessel DL (2000) Changes in whole blood lactate levels during cardiopulmonary bypass for surgery for congenital cardiac disease: an early indicator of morbidity and mortality. J Thorac Cardiovasc Surg 119(1):155-162
28. Takami Y, Masumoto H (2005) Mixed venous-arterial CO2 tension gradient after cardiopulmonary bypass. Asian Cardiovasc Thorac Ann 13(3):255-260
29. Hatherill M, Sajjanhar T, Tibby SM et al (1997) Serum lactate as a predictor of mortality after paediatric cardiac surgery. Arch Dis Child 77(3):235-238
30. Tibby SM, Murdoch IA (2003) Monitoring cardiac function in intensive care. Arch Dis Child 88(1):46-52
31. Tibby SM, Murdoch IA (2002) Measurement of cardiac output and tissue perfusion. Curr Opin Pediatr 14(3):303-309
32. Tibby SM, Hatherill M, Marsh MJ, Murdoch IA (1997) Clinicians' abilities to estimate cardiac index in ventilated children and infants. Arch Dis Child 77(6):516-518
33. Romagnoli C, De Carolis MP, Muzii U et al (1992) Effectiveness and side effects of two different doses of caffeine in preventing apnea in premature infants. Ther Drug Monit 14(1):14-19
34. Olson KR, Benowitz NL, Woo OF, Pond SM (1985) Theophylline overdose: acute single ingestion versus chronic repeated overmedication. Am J Emerg Med 3(5):386-394
35. Dager WE, Albertson TE (1992) Impact of therapeutic drug monitoring of intravenous theophylline regimens on serum theophylline concentrations in the medical intensive care unit. Ann Pharmacother 26(10):1287-1291
36. Paloucek FP, Rodvold KA (1988) Evaluation of theophylline overdoses and toxicities. Ann Emerg Med 17(2):135-144
37. Smith AH, Owen J, Borgman KY, Fish FA, Kannankeril PJ (2011) Relation of milrinone after surgery for congenital heart disease to significant postoperative tachyarrhythmias. Am J Cardiol 108:1620-1624
38. Baer AB, Holstege CP (2002) Milrinone overdose induced hypotension reversed by vasopressin and norepinephrine infusions. J Toxicol Clin Toxicol 40(5):690
39. Choong K, Bohn D, Fraser DD, Gaboury I, Hutchison JS, Joffe AR, Litalien C, Menon K, McNamara P, Ward RE (2009) Canadian Critical Care Trials Group. Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med 180(7):632-639
40. Plötz FB, Bouma AB, van Wijk JA, Kneyber MC, Bökenkamp A (2008) Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria. Intensive Care Med 34(9):1713-1717